BIIB 142.26 ▼ -0.97% Live Trading Data - Stocknear

Biogen Inc.

NASDAQ: BIIB · Real-Time Price · USD
142.26
-1.40 (-0.97%)
At close: Oct 16, 2025, 3:59 PM
141.50
-0.53%
After-hours: Oct 16, 2025, 07:53 PM EDT
-0.97%
Bid 141.82
Market Cap 20.86B
Revenue (ttm) 10B
Net Income (ttm) 1.53B
EPS (ttm) 10.45
PE Ratio (ttm) 13.61
Forward PE 9.18
Analyst Hold
Dividends n/a
Ask 142.32
Volume 1,422,112
Avg. Volume (20D) 1,735,599.5
Open 144.05
Previous Close 143.66
Day's Range 141.70 - 147.48
52-Week Range 110.04 - 191.19
Beta 0.13
Ex-Dividend Date n/a

About BIIB

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BIIB
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BIIB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Biogen Inc. is scheduled to release its earnings on Oct 30, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+10.09%
Shares of several drugmakers are trading higher af... Unlock content with Pro Subscription
3 weeks ago
-0.96%
Biogen shares are trading lower after the FDA issued a Complete Response Letter for the company's sNDA for the high-dose regimen of nusinersen for spinal muscular atrophy.